4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C33H46N2O2 — CID 135311596

IUPAC4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
SMILESCC(CCC(=O)O)C1CCC2C3CC[C@@H]4C[C@H](Nc5ccc6ccccc6n5)CC[C@]4(C)C3CC[C@]12C
InChIInChI=1S/C33H46N2O2/c1-21(8-15-31(36)37)26-12-13-27-25-11-10-23-20-24(16-18-32(23,2)28(25)17-19-33(26,27)3)34-30-14-9-22-6-4-5-7-29(22)35-30/h4-7,9,14,21,23-28H,8,10-13,15-20H2,1-3H3,(H,34,35)(H,36,37)/t21?,23-,24-,25?,26?,27?,28?,32+,33-/m1/s1
InChIKeyHYDORHBTJOYTEH-OZIYIZLTSA-N
MW502.74 g/mol
LogP8.18
Rot. Bonds6

About 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (PubChem CID 135311596) has the molecular formula C33H46N2O2 and a molecular weight of 502.74 g/mol. Its IUPAC name is 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid.

Molecular Properties

Compound Name4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
PubChem CID135311596
Molecular FormulaC33H46N2O2
Molecular Weight502.74 g/mol
Exact Mass502.36
IUPAC Name4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
SMILESCC(CCC(=O)O)C1CCC2C3CC[C@@H]4C[C@H](Nc5ccc6ccccc6n5)CC[C@]4(C)C3CC[C@]12C
InChIInChI=1S/C33H46N2O2/c1-21(8-15-31(36)37)26-12-13-27-25-11-10-23-20-24(16-18-32(23,2)28(25)17-19-33(26,27)3)34-30-14-9-22-6-4-5-7-29(22)35-30/h4-7,9,14,21,23-28H,8,10-13,15-20H2,1-3H3,(H,34,35)(H,36,37)/t21?,23-,24-,25?,26?,27?,28?,32+,33-/m1/s1
InChIKeyHYDORHBTJOYTEH-OZIYIZLTSA-N
XLogP8.18
TPSA62.22 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds6
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500502.74
LogP ≤ 58.18
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
The IUPAC name of 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (CID 135311596) is 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid.
What is the SMILES notation for 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
The canonical SMILES for 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is CC(CCC(=O)O)C1CCC2C3CC[C@@H]4C[C@H](Nc5ccc6ccccc6n5)CC[C@]4(C)C3CC[C@]12C.
What is the InChIKey of 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
The InChIKey is HYDORHBTJOYTEH-OZIYIZLTSA-N. The full InChI is InChI=1S/C33H46N2O2/c1-21(8-15-31(36)37)26-12-13-27-25-11-10-23-20-24(16-18-32(23,2)28(25)17-19-33(26,27)3)34-30-14-9-22-6-4-5-7-29(22)35-30/h4-7,9,14,21,23-28H,8,10-13,15-20H2,1-3H3,(H,34,35)(H,36,37)/t21?,23-,24-,25?,26?,27?,28?,32+,33-/m1/s1.
What are the key properties of 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid has a molecular weight of 502.74 g/mol, XLogP of 8.18, 6 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(3R,5R,10S,13R)-10,13-dimethyl-3-(quinolin-2-ylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is sourced from PubChem (CID 135311596), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).